Johnson & Johnson (JNJ) Tax Rate: 17.73%
Is Johnson & Johnson’s tax rate high or low?
Johnson & Johnson's tax rate of 17.73% is 40% above its 5-year average of 12.64%, near the high end of its 5-year range (7.18%–17.73%).
The tax rate for Johnson & Johnson (JNJ) is 17.73%. It is above its 12-month average by 6.04% (16.72%).
JNJ Tax Rate Chart
JNJ Average Tax Rate Chart
JNJ Current vs Average Tax Rate Chart
JNJ Tax Rate Metrics
TAX RATE
17.73%
TAX RATE AVG TTM
16.72%
TAX RATE AVG 3Y
14.46%
TAX RATE AVG 5Y
12.64%
TAX RATE AVG 10Y
21.13%
TAX RATE AVG 15Y
20.65%
TAX RATE AVG 20Y
21.14%
CURRENT VS TTM AVG
+6.04%
CURRENT VS 3Y AVG
+22.59%
CURRENT VS 5Y AVG
+40.27%
CURRENT VS 10Y AVG
-16.10%
CURRENT VS 15Y AVG
-14.14%
CURRENT VS 20Y AVG
-16.14%
Johnson & Johnson Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Johnson & Johnson Tax Rate FAQ
- What is the tax rate for Johnson & Johnson (JNJ)?
- The tax rate for JNJ stock is 17.73%.
- Is Johnson & Johnson's tax rate high or low?
- Johnson & Johnson's tax rate of 17.73% is 40% above its 5-year average of 12.64%, near the high end of its 5-year range (7.18%–17.73%).
- What is the TTM average tax rate for Johnson & Johnson (JNJ)?
- The TTM average tax rate for JNJ stock is 16.72%.
- What is the 3Y average tax rate for Johnson & Johnson (JNJ)?
- The 3Y average tax rate for JNJ stock is 14.46%.
- What is the 5Y average tax rate for Johnson & Johnson (JNJ)?
- The 5Y average tax rate for JNJ stock is 12.64%.
- What is the 10Y average tax rate for Johnson & Johnson (JNJ)?
- The 10Y average tax rate for JNJ stock is 21.13%.
- What is the 15Y average tax rate for Johnson & Johnson (JNJ)?
- The 15Y average tax rate for JNJ stock is 20.65%.
- What is the 20Y average tax rate for Johnson & Johnson (JNJ)?
- The 20Y average tax rate for JNJ stock is 21.14%.
Johnson & Johnson Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-12-28 | 17.73% |
| 2024-12-29 | 15.71% |
| 2023-12-31 | 8.97% |
| 2023-01-01 | 15.44% |
| 2022-01-02 | 7.18% |
| 2021-01-03 | 10.81% |
| 2019-12-31 | 12.75% |
| 2018-12-31 | 15.01% |
| 2017-12-31 | 92.64% |
| 2016-12-31 | 16.48% |
| 2015-12-31 | 19.73% |
| 2014-12-31 | 20.62% |
| 2013-12-31 | 10.60% |
| 2012-12-31 | 23.67% |
| 2011-12-31 | 21.75% |
| 2010-12-31 | 21.32% |
| 2009-12-31 | 22.15% |
| 2008-12-31 | 23.51% |
| 2007-12-31 | 20.38% |
| 2006-12-31 | 24.23% |
| 2005-12-31 | 23.30% |
| 2004-12-31 | 33.66% |
| 2003-12-31 | 30.18% |
| 2002-12-31 | 29.00% |
| 2001-12-31 | 28.23% |
| 2000-12-31 | 27.88% |
| 1999-12-31 | 27.29% |
| 1998-12-31 | 28.19% |
| 1997-12-31 | 27.82% |
| 1996-12-31 | 28.42% |
Related Metrics
About Johnson & Johnson
Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: Innovative Medicine and MedTech. The Innovative Medicine segment, formerly known as Pharmaceuticals, specializes in prescription drugs designed to treat complex ailments such as rheumatoid arthritis, various forms of cancer, HIV/AIDS, and neurodegenerative disorders. Its MedTech division, encompassing Medical Devices, delivers cutting-edge technological solutions, including electrophysiology equipment, neurovascular care products, orthopaedic implants for hips, knees, and spine, advanced surgical technologies, and ACUVUE brand disposable contact lenses. These two streamlined segments primarily cater to a client base comprising hospitals, medical professionals, wholesale distributors, and retail outlets. From its headquarters in New Brunswick, New Jersey, Johnson & Johnson continues to uphold its enduring mission of advancing human health, a commitment it has maintained since its founding in 1886.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joaquin Duato